| Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study BE Young, SW Fong, YH Chan, TM Mak, LW Ang, DE Anderson, CYP Lee, ... The lancet 396 (10251), 603-611, 2020 | 438 | 2020 |
| Malaria parasites: the great escape L Rénia, YS Goh Frontiers in immunology 7, 463, 2016 | 113 | 2016 |
| A specific PfEMP1 is expressed in P. falciparum sporozoites and plays a role in hepatocyte infection G Zanghì, SS Vembar, S Baumgarten, S Ding, J Guizetti, JM Bryant, ... Cell reports 22 (11), 2951-2963, 2018 | 87 | 2018 |
| Novel approaches to identify protective malaria vaccine candidates WN Chia, YS Goh, L Rénia Frontiers in microbiology 5, 586, 2014 | 63 | 2014 |
| Human IgG isotypes and activating Fcγ receptors in the interaction of Salmonella enterica serovar Typhimurium with phagocytic cells YS Goh, AJ Grant, O Restif, TJ McKinley, KL Armour, MR Clark, ... Immunology 133 (1), 74-83, 2011 | 59 | 2011 |
| Vaccination with sporozoites: models and correlates of protection YS Goh, D McGuire, L Rénia Frontiers in immunology 10, 433221, 2019 | 46 | 2019 |
| Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19 YS Goh, JM Chavatte, AL Jieling, B Lee, PX Hor, SN Amrun, CYP Lee, ... Cell Reports Medicine 2 (2), 2021 | 43 | 2021 |
| Monoclonal Antibodies of a Diverse Isotype Induced by an O-Antigen Glycoconjugate Vaccine Mediate In Vitro and In Vivo Killing of African Invasive Nontyphoidal … YS Goh, S Clare, F Micoli, A Saul, P Mastroeni, CA MacLennan Infection and Immunity 83 (9), 3722-3731, 2015 | 41 | 2015 |
| Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2 YH Chan, SW Fong, CM Poh, G Carissimo, NKW Yeo, SN Amrun, YS Goh, ... EMBO molecular medicine 13 (6), e14045, 2021 | 37 | 2021 |
| Breadth of humoral response and antigenic targets of sporozoite‐inhibitory antibodies associated with sterile protection induced by controlled human malaria infection K Peng, YS Goh, A Siau, JF Franetich, WN Chia, ASM Ong, B Malleret, ... Cellular microbiology 18 (12), 1739-1750, 2016 | 36 | 2016 |
| Invasive African nontyphoidal Salmonella requires high levels of complement for cell-free antibody-dependent killing YS Goh, CA MacLennan Journal of immunological methods 387 (1-2), 121-129, 2013 | 32 | 2013 |
| Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians B Wang, YS Goh, SW Fong, BE Young, EZX Ngoh, JM Chavatte, ... The Lancet Regional Health–Western Pacific 15, 2021 | 29 | 2021 |
| Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection MZ Tay, A Rouers, SW Fong, YS Goh, YH Chan, ZW Chang, W Xu, ... EMBO molecular medicine 14 (3), e15227, 2022 | 26 | 2022 |
| IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal Salmonella Develop at Discordant Rates AE Schager, CC Dominguez-Medina, F Necchi, F Micoli, YS Goh, ... MBio 9 (2), 10.1128/mbio. 02379-17, 2018 | 26 | 2018 |
| Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose L Renia, YS Goh, A Rouers, N Le Bert, WN Chia, JM Chavatte, SW Fong, ... Nature Communications 13 (1), 4615, 2022 | 20 | 2022 |
| Bactericidal Immunity to Salmonella in Africans and Mechanisms Causing Its Failure in HIV Infection YS Goh, F Necchi, CM O’Shaughnessy, F Micoli, M Gavini, SP Young, ... PLoS neglected tropical diseases 10 (4), e0004604, 2016 | 18 | 2016 |
| Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals YS Goh, A Rouers, SW Fong, NZ Zhuo, PX Hor, CY Loh, Y Huang, ... Frontiers in immunology 13, 1031852, 2022 | 16 | 2022 |
| Robust virus-specific adaptive immunity in COVID-19 patients with SARS-CoV-2 Δ382 variant infection SW Fong, NKW Yeo, YH Chan, YS Goh, SN Amrun, N Ang, ... Journal of Clinical Immunology, 1-16, 2022 | 16 | 2022 |
| Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant CYP Lee, SN Amrun, RSL Chee, YS Goh, TM Mak, S Octavia, NKW Yeo, ... Clinical & translational immunology 10 (2), e1241, 2021 | 16 | 2021 |
| Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore B Wang, YS Goh, T Prince, EZX Ngoh, SNM Salleh, PX Hor, CY Loh, ... npj Vaccines 6 (1), 125, 2021 | 15 | 2021 |
